查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564071

全球細胞擴增市場

Cell Expansion
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到2030年，全球電池擴產市場預計將達到869億美元

預計2023年全球電池擴產市場規模為331億美元，預計到2030年將達869億美元，2023年至2030年複合年成長率為14.8%。細胞擴增耗材是本報告分析的細分市場之一，複合年成長率為16.0%，預計到分析期末將達到424億美元。在分析期間，蜂窩擴展設備領域的複合年成長率預計為 12.5%。

美國市場預計91億美元，中國預計複合年成長率13.9%

預計到 2023 年，美國電池市場的規模將擴大至 91 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達131億美元，2023-2030年分析期間複合年成長率為13.9%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 13.1% 和 12.3%。在歐洲，德國預計複合年成長率為 10.6%。

不斷擴大的全球電池市場 - 主要趨勢和促進因素總結

細胞擴增將如何徹底改變治療和研究？

細胞擴增是生物醫學研究和先進治療方法開發的關鍵過程，允許從有限的起始群體中產生大量細胞。這項技術是再生醫學、腫瘤學和免疫治療等領域的基礎，這些領域的研究、藥物發現和治療需要大量的功能性細胞。在幹細胞治療的背景下，細胞擴增能夠產生足夠的幹細胞用於組織再生和退化性疾病的治療。在癌症研究中，T細胞等免疫細胞的增殖能力為CAR T細胞療法等免疫療法鋪平了道路。透過提供一種有效的方法來增加細胞數量，同時保持細胞活力和功能，細胞擴增正在推動臨床和研究領域的創新。反應器技術和培養基的進步使細胞生長過程更加可擴展和精確，使科學家和臨床醫生能夠生產用於各種治療應用的高品質細胞。

為什麼細胞擴增對於再生醫學和免疫療法至關重要？

細胞擴增對於再生醫學和免疫療法的進步至關重要，這兩個領域是現代醫療保健中最有前景的領域。再生醫學嚴重依賴幹細胞，幹細胞具有分化成各種類型細胞並修復受損組織的能力。為了開發針對脊髓損傷、心臟病和糖尿病等疾病的有效治療方法，研究人員必須培養大量幹細胞。面臨的挑戰是維持幹細胞的多功能並維持其分化為所需細胞的能力。另一方面，免疫療法依賴 T 細胞等免疫細胞的增殖。例如，CAR-T細胞療法的成功取決於將T細胞擴增至足夠數量以實現治療效果的能力。隨著此類治療方法的採用不斷增加，對強大的細胞擴增系統的需求日益成長，該系統可以支持大規模生產而不影響細胞安全性和功效。隨著對細胞療法的需求不斷增加，細胞擴增技術變得越來越複雜，以應對臨床應用中可擴展性和法規遵循的挑戰。

科技進步如何徹底改變細胞擴增？

技術進步徹底改變了細胞​​擴增的過程，使其更有效率、可擴展並適應現代科學的需求。最重要的技術創新之一是反應器的開發。反應器為細胞生長提供受控環境，使細胞能夠大規模擴增，同時保持最佳的活力和功能條件。這些反應器配備了自動化系統，可監測和調整溫度、氧氣和營養水平等關鍵參數，確保結果的一致性和可重複性。此外，培養基的創新使得最佳化特定細胞類型的營養需求成為可能，進一步提高擴增細胞的品質和產量。微載體為細胞在懸浮液中生長提供了表面，擴大了反應器的容量，使它們能夠更有效地產生更高的細胞密度。自動化和人工智慧 (AI) 的進步也發揮著關鍵作用，使細胞培養環境中的即時監控和決策成為可能。這些技術正在幫助研究人員和臨床醫生減少生產治療細胞的時間和成本，同時提高擴充性並簡化臨床和工業應用的流程。

推動細胞擴增市場成長的因素有哪些？

細胞擴增市場的成長是由多種因素所推動的，例如對細胞療法的需求增加、生物加工技術的進步以及慢性病盛行率的增加。隨著越來越多的細胞療法（例如 CAR-T 細胞療法和幹細胞療法）進入臨床，對可靠且可擴展的細胞擴增方法的需求正在迅速增加。技術創新，特別是反應器和自動化，使得生產大量細胞變得更加容易，同時保持品質和治療潛力。細胞擴增在再生醫學（利用幹細胞修復或替換受損組織）中的日益使用也是一個重要的促進因素，因為它需要高效且可擴展的系統來生產這些治療所需的大量細胞。此外，癌症、糖尿病和心血管疾病的盛行率日益增加，正在刺激依賴擴增細胞的新治療方法的研究，例如免疫療法和再生療法。此外，細胞治療方法核准的監管進展正在鼓勵對生物製程基礎設施的投資，進一步推動市場成長。隨著消費者對個人化醫療意識的增強，對客製化細胞療法的需求預計將加速，為創新細胞擴增技術的發展創造新的機會。總的來說，這些因素推動了細胞擴增市場的快速擴張，使其成為生物技術和醫療保健的關鍵成長領域。

受訪企業範例（共12家）

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP10941

Global Cell Expansion Market to Reach US$86.9 Billion by 2030

The global market for Cell Expansion estimated at US$33.1 Billion in the year 2023, is expected to reach US$86.9 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2023-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the analysis period. Growth in the Cell Expansion Instruments segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.1 Billion While China is Forecast to Grow at 13.9% CAGR

The Cell Expansion market in the U.S. is estimated at US$9.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$13.1 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.1% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Cell Expansion Market - Key Trends and Drivers Summarized

How Is Cell Expansion Transforming Therapeutics and Research?

Cell expansion is a pivotal process in biomedical research and the development of advanced therapies, enabling the production of large quantities of cells from a limited starting population. This technique is fundamental in fields such as regenerative medicine, oncology, and immunotherapy, where vast numbers of functional cells are required for research, drug discovery, or therapeutic use. In the context of stem cell therapy, cell expansion allows for the generation of enough stem cells to support tissue regeneration or to treat degenerative diseases. In cancer research, the ability to expand immune cells, such as T cells, has paved the way for immunotherapies like CAR-T cell treatments, which require billions of engineered immune cells to effectively target and destroy cancerous cells. By providing an efficient means of increasing cell numbers while maintaining their viability and functionality, cell expansion is driving innovation in both clinical and research environments. With advancements in bioreactor technology and culture media, the process of expanding cells has become more scalable and precise, ensuring that scientists and clinicians can produce high-quality cells for a variety of therapeutic applications.

Why Is Cell Expansion Critical for Regenerative Medicine and Immunotherapy?

Cell expansion is indispensable for the advancement of regenerative medicine and immunotherapy, two of the most promising fields in modern healthcare. Regenerative medicine relies heavily on stem cells, which have the ability to differentiate into various cell types and repair damaged tissues. To create effective treatments for conditions such as spinal cord injuries, heart disease, or diabetes, researchers must expand stem cells in large quantities. The challenge lies in maintaining the pluripotency of these cells during the expansion process, ensuring that they retain their capacity to transform into the needed cell types. Immunotherapy, on the other hand, depends on the expansion of immune cells like T cells, which are modified and multiplied to fight diseases such as cancer. The success of CAR-T cell therapy, for instance, hinges on the ability to expand these engineered T cells to sufficient numbers to achieve therapeutic efficacy. The growing adoption of these therapies has increased the need for robust cell expansion systems that can support large-scale production without compromising the safety and potency of the cells. As the demand for cell-based therapies continues to rise, cell expansion technologies are becoming more sophisticated to meet the challenges of scalability and regulatory compliance in clinical applications.

How Are Technological Advancements Revolutionizing Cell Expansion?

Technological advancements are revolutionizing the process of cell expansion, making it more efficient, scalable, and adaptable to the needs of modern science. One of the most significant innovations is the development of bioreactors, which provide controlled environments for cell growth, enabling the expansion of cells on a large scale while maintaining optimal conditions for viability and function. These bioreactors are equipped with automated systems that monitor and adjust critical parameters such as temperature, oxygen, and nutrient levels, ensuring consistent and reproducible results. Additionally, innovations in culture media have made it possible to optimize the nutritional needs of specific cell types, further improving the quality and yield of expanded cells. Microcarriers, which offer a surface for cells to grow in suspension, have expanded the capacity of bioreactors, making them more efficient in producing high cell densities. Advances in automation and artificial intelligence (AI) are also playing a crucial role, enabling real-time monitoring and decision-making in cell culture environments. These technologies help researchers and clinicians streamline the cell expansion process, reducing the time and cost associated with producing therapeutic cells while increasing scalability for clinical and industrial use.

What Factors Are Driving Growth in the Cell Expansion Market?

The growth in the cell expansion market is driven by several factors, including the increasing demand for cell-based therapies, advancements in bioprocessing technologies, and the growing prevalence of chronic diseases. As more cell-based therapies, such as CAR-T cell treatments and stem cell therapies, enter clinical practice, the need for reliable and scalable cell expansion methods is rising rapidly. Technological innovations, particularly in bioreactors and automation, have made it easier to produce large quantities of cells while maintaining their quality and therapeutic potential. The expanding use of cell expansion in regenerative medicine, where stem cells are employed to repair or replace damaged tissues, is another significant driver, as it requires efficient and scalable systems to produce the high volumes of cells necessary for these treatments. Moreover, the growing incidence of cancer, diabetes, and cardiovascular diseases is fueling research into new therapies that depend on expanded cells, such as immunotherapies and regenerative treatments. Additionally, regulatory advancements in the approval of cell-based therapies are encouraging investments in bioprocessing infrastructure, further propelling market growth. As consumer awareness of personalized medicine increases, the demand for customized cell therapies is expected to accelerate, creating new opportunities for the development of innovative cell expansion technologies. These factors are collectively driving the rapid expansion of the cell expansion market, positioning it as a key area of growth in biotechnology and healthcare.

Select Competitors (Total 12 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Expansion - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Cell-Based Therapies Expands Market for Cell Expansion Technologies
    • Advancements in Bioreactor Technology Propel Growth in Scalable Cell Expansion
    • Increasing Focus on Personalized Medicine Strengthens Business Case for Cell Expansion
    • Stem Cell Research and Regenerative Medicine Fuel Market for Optimized Cell Expansion
    • Technological Innovations in 3D Cell Culture Expand Opportunities in Cell Expansion
    • Automation in Cell Expansion Systems Spurs Market Growth in High-Throughput Applications
    • Adoption of CAR-T Cell Therapy Boosts Need for Large-Scale Cell Expansion Solutions
    • Rising Prevalence of Chronic Diseases Accelerates Demand for Advanced Cell Expansion Techniques
    • Emergence of Allogeneic Therapies Creates New Opportunities for Scalable Cell Expansion
    • Shift Toward Automation and AI-Driven Systems Creates New Possibilities in Cell Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Expansion Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Human Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Human Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Animal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Animal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cell Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Cell Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: China 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of World 7-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2024 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of World 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION